| |
| |
|
| Insider
Information: |
Quimi Daphne |
| Relationship: |
|
| City: |
Cranbury |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
403,532 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$4,228,425 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
403,532 |
|
|
| Total
Value |
$4,228,425 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amicus Therapeutics Inc |
FOLD |
Chief Financial Officer |
2023-01-18 |
398,532 |
2014-04-10 |
0 |
Premium* |
|
|
Amylyx Pharmaceuticals, Inc. |
AMLX |
|
2024-05-15 |
5,000 |
2024-05-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2023-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
73,508 |
393,655 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2022-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
73,136 |
335,947 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2020-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
71,868 |
194,387 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2023-01-11 |
4 |
A |
$0.00 |
$0 |
D/D |
58,824 |
440,020 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2019-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
57,471 |
121,803 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
VP Finance and Controller |
• – – |
2014-04-10 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
50,000 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2022-01-14 |
4 |
A |
$0.00 |
$0 |
D/D |
36,840 |
368,746 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2021-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
33,131 |
254,638 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
SVP, Finance |
• – – |
2017-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
30,487 |
54,676 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2020-12-15 |
4 |
OE |
$2.45 |
$99,222 |
D/D |
30,321 |
248,500 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2023-01-11 |
4 |
D |
$12.02 |
$355,371 |
D/D |
(29,565) |
410,455 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
VP Finance and Controller |
• – – |
2015-05-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,000 |
25,000 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2020-01-10 |
4 |
A |
$0.00 |
$0 |
D/D |
24,496 |
202,487 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2020-07-01 |
4 |
OE |
$2.45 |
$52,054 |
D/D |
19,872 |
214,051 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2021-04-06 |
4 |
A |
$0.00 |
$0 |
D/D |
19,295 |
290,629 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2022-01-14 |
4 |
D |
$10.53 |
$198,417 |
D/D |
(18,843) |
349,903 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2021-03-05 |
4 |
OE |
$2.94 |
$48,886 |
D/D |
16,628 |
275,998 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2022-01-02 |
4 |
D |
$11.55 |
$182,236 |
D/D |
(15,778) |
264,349 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2023-01-02 |
4 |
D |
$12.21 |
$185,165 |
D/D |
(15,165) |
320,147 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2021-01-02 |
4 |
D |
$23.09 |
$350,137 |
D/D |
(15,164) |
226,560 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2020-01-09 |
4 |
AS |
$9.93 |
$148,952 |
D/D |
(15,000) |
166,969 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
SVP, Finance |
• – – |
2018-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
12,609 |
67,285 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2019-04-11 |
4 |
A |
$0.00 |
$0 |
D/D |
12,347 |
130,300 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2020-01-10 |
4 |
D |
$9.46 |
$114,135 |
D/D |
(12,065) |
190,422 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Vice President Finance |
• – – |
2015-10-01 |
4 |
AS |
$13.13 |
$147,761 |
D/D |
(11,250) |
5,688 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
